Transcripts Northwest Biotherapeutics, Inc. Börse Stuttgart

Stocks

Market Closed - Börse Stuttgart Other stock markets 05:56:28 18/07/26 am AEST			5-day change	1st Jan Change
0.1450 ^EUR	+11.54%		-9.38%	-29.61%

09/07	Northwest Biotherapeutics Presents Updated Survival Data from Phase III Trial of Dcvax-L for Glioblastoma	CI
16/05	Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

30/06/24	Northwest Biotherapeutics, Inc. - Shareholder/Analyst Call
31/12/22	Northwest Biotherapeutics, Inc. - Shareholder/Analyst Call
19/04/20	Northwest Biotherapeutics, Inc. - Shareholder/Analyst Call